Loteprednol / tobramycin
Anti-inflammatory · Rx
RxAnti-inflammatorySteroid
| Strength | Loteprednol 0.5% + tobramycin 0.3% |
|---|---|
| Typical quantity | 5-10 mL bottle (generic available) |
| Cash cost / month | Moderate · ~$20-100 |
| Drug class | Antibiotic + corticosteroid (combination) |
| Mechanism of action | Ester corticosteroid (lower IOP/cataract liability) plus aminoglycoside cover. |
| Indication / reason for use | Steroid-responsive ocular inflammation with a bacterial infection or risk. |
| Usual adult dosing | 1-2 drops q4-6h; may dose q1-2h for the first 24-48 h. Shake well. |
| Preservative | BAK 0.01% |
| Contact lenses | No lens wear during treatment. |
| Common / important adverse effects | IOP rise (lower risk than dexamethasone combos), aminoglycoside toxicity, secondary infection. |
| Contraindications & cautions | HSV epithelial keratitis, fungal/mycobacterial infection. |
| Pregnancy / lactation | Limited data. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | Zylet |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.